Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2016, Vol. 43 Issue (1): 119-122    DOI: 10.12891/ceog2105.2016
Case Report Previous articles | Next articles
Dextroamphetamine sulfate treatment eradicates long-term chronic severe headaches from temporomandibular joint syndrome - a case that emphasizes the role of the gynecologist in treating headaches in women
J.H. Check1, 2, *()
1Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ
2Cooper Institute For Reproductive Hormonal Disorders, P.C. Mt. Laurel, NJ (USA)
Download:  PDF(61KB)  ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To test sympathomimetic amine therapy on another type of chronic headache syndrome - headaches from temporal mandibular joint (TMJ) syndrome. Materials and Methods: A woman with 20 years of severe daily pain from TMJ refractory to all therapies was treated with dextroamphetamine sulfate. Results: The woman showed immediate 100% relief from sympathomimetic amine treatment saving her from an expensive jaw breaking operation that was only given a slight chance of helping. Conclusions: Unfortunately most treating physicians are unaware of this defect of sympathetic nervous system hypofunction leading to the absorption of toxins, which when it involves brain tissue, leads to severe headaches. Thus, the gynecologist who is aware of this syndrome because sympathetic nervous system hypofunction is the most common cause of pelvic pain, may need to intervene in women with chronic headaches, even TMJ.
Key words:  Sympathomimetic amines      Sympathetic neural hyperalgesia syndrome      Temporomandibular joint syndrome      Migraine headaches     
Published:  10 February 2016     
*Corresponding Author(s):  J.H. CHECK     E-mail:  laurie@ccivf.com

Cite this article: 

J.H. Check. Dextroamphetamine sulfate treatment eradicates long-term chronic severe headaches from temporomandibular joint syndrome - a case that emphasizes the role of the gynecologist in treating headaches in women. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 119-122.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog2105.2016     OR     https://ceog.imrpress.com/EN/Y2016/V43/I1/119

[1] J.H. Check, M. Citerone, T. Citerone. The increased cellular permeability syndrome as a cause of traumatic stuttering[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 773-774.
[2] J.H. Check. Changing the name of a syndrome: sympathetic neural hyperalgesia edema syndrome becomes – the increased cellular permeability syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 819-823.
[3] J. H. Check, R. Cohen. Marked improvement of severe gastroparesis following high dosage, but very well tolerated, dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 611-612.
[4] J. H. Check. Very unusual symptoms consistent with a possible migraine immediately following the injection of recombinant follitropin beta[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 484-485.
[5] J.H. Check. Chronic unremitting lower abdominal pain quickly abrogated following treatment with amphetamine[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 109-111.
[6] J.H. Check, R. Cohen. Complete resolution of frozen shoulder syndrome in a woman treated with dextroamphetamine sulfate for chronic urinary urgency[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 679-680.
[7] J. H. Check, R. Cohen. An update on the treatment of female alopecia and the introduction of a potential novel therapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(4): 411-415.
[8] J.H. Check, A. Whetstone. Failed surgical therapy for chronic back pain and sciatica may be due to hypofunction of the sympathetic nervous system[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(4): 529-530.
[9] J.H. Check, R. Cohen. Marked improvement of vulvovaginitis of unknown origin in a pediatric patient - case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(6): 723-724.
[10] J.H. Check, R. Cohen. The triad of luteal phase ocular migraines, interstitial cystitis, and dyspareunia as a result of sympathetic nervous system hypofunction[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 575-577.
[11] J.H. Check, R. Cohen. Sympathomimetic amine therapy found effective for treatment of refractory chronic complex regional pain syndrome (reflex sympathetic dystrophy)[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(4): 478-482.
[12] C.P. Potestio, J.H. Check, J. Mitchell-Williams. Improvement in symptoms of the syndrome of mitochondrial encephalopathy, lactic acidosis, and stroke-like symptoms (MELAS) following treatment with sympathomimetic amines – possible implications for improving fecundity in women of advanced reproductive age[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(3): 343-345.
[13] J.H. Check, S. Chan. Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(2): 202-204.
[14] J.H. Check, R. Cohen. Severe headaches from intracranial hypertension (pseudotumor cerebri) abrogated by treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(2): 211-213.
[15] J.H. Check, R. Cohen, B. Katsoff. The sympathetic neural hyperalgesia/edema syndrome, a common cause of female pelvic pain, manifesting as a pseudopheochromocytoma with marked clinical improvement with sympathomimetic amines[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(1): 75-77.
No Suggested Reading articles found!